A one-stop shop for innovators who are looking to receive guidance on their innovation projects and a coordinating centre for innovation resources across the cluster.
The SingHealth AI Office (AIO) supports clinical and non-clinical AI projects through the 4 pillars, providing guidance, technical AI solutions, commercial engagement and supporting of AI regulatory & governance.
IAU is a health services research unit that focuses on evaluating the impact of healthcare innovations.
Navigate the structured innovation process, from idea conception to implementation. Our three-phase journey ensures your innovations meet the required standards while receiving the right resources and support.
Have an idea? Get advice from a diverse panel of subject matter experts.
Support innovation for testing feasibility & test-bedding in clinical practice and bridge the gaps for adoption & implementation across clusters. (Intranet access only)
Kick-start and translate your early stage innovation (Intranet access only)
Please access the relevant forms/templates here
The DHA program aims to bring together the various stakeholders in the healthcare system to enable the development, integration and implementation of the digital health solutions in care delivery organisations. (Intranet access only)
The SingHealth-A*STAR HTP Grant aims to accelerate the translation, deployment and commercialisation of joint healthcare research and innovation projects to generate healthcare impact, improve population health and create economic value. (Intranet access only)
A static simple grant calendar to showcase all research and innovation grants for the year.
Do you require funding for your innovation? Find out more! (Intranet access only)
Support programmes that are backed by a sustained track record of collaboration in innovation and/or research between the two organizations, and programmes with potential translation and commercialisation of joint projects (Intranet access only)
A signature biennial event of the SingHealth Duke-NUS Academic Medicine Centre. This congress provides a unique platform for thought leaders, healthcare professionals, researchers and educators to convene, ignite ideas and share insights on the latest innovations in academic medicine.
Learn more about innovation events across the AMC.
Find out more on our partnership criteria and how to reach us here.
Find out more about the type of MOUs and partnership agreements which we have signed with our existing partners.
Explore collaboration opportunities with our healthcare professionals. Find our more how you can do so at A.L.I.C.E Lee Innovation Centre.
The establishment of AMII signifies a stronger support for innovation in the healthcare sector and it aligns closely to the AMC’s three-fold thrust mission to provide excellent patient care through:
Supported by SingHealth Office for Innovation and Duke-NUS Office of Innovation and Entrepreneurship, AMII is a convening platform that brings together innovators in the AMC to foster a culture of innovation.
The key aims/deliverables of AMII are:
AMII will focus its efforts along 5 initial key enablers. These enablers are termed as priority areas to create policies, frameworks, structures and processes. These five priority areas are:
These priority areas will bring together representatives from across the AMC and relevant stakeholders into the eco-system to form the respective convening groups and work towards AMII’s key deliverables.
The AMII Innovation Council serves as a convening forum for the innovation community across the AMC to perform the following roles:
The AMII EXCO, comprising the Innovation Council Chairs, priority area leads and other key leaders, will:
If you have any innovation related queries, please write to us at innovate@singhealth.com.sg.
© 2025 SingHealth Group. All Rights Reserved.